SNDL Inc.
SNDL Nasdaq· Medicinal Chemicals & Botanical Products
KIRA · Stoqly’s AI analyst, in plain words
- SNDL Inc. had $677M of revenue in fiscal 2025, up 0.7% on the year before. Over five years, revenue changed +71.7% a year on average.
- Its operating margin was −0.7%, up 10.6 pts: of every 100 in sales, about −1 is left after running the business.
- SNDL Inc. lost $11.3M in fiscal 2025.
- Free cash flow was $41.6M in fiscal 2025, 6.1% of revenue.
- SNDL Inc. returned $11.0M to shareholders in fiscal 2025, 26% of free cash flow. The diluted share count fell 2.3%.
Market cap
—
P/E
—
Revenue
$677M
Net income
−$11.3M
Free cash flow
$41.6M
Operating margin
−0.7%
SNDL Inc. in 30 seconds · fiscal 2025
Are sales growing?
+0.7%
Only a little. Sales grew 0.7% last year.
Does it make a profit?
−1.7%
No. It lost money last year.
Does profit turn into cash?
6.1%
Partly. 6.1% of sales ends up as free cash.
How healthy are the accounts?
5 / 8
Mixed. It passes 5 of 8 health tests.
What SNDL Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 40-F · Mar 12, 2026
- Legal name
- SNDL Inc.
- CIK
- 0001766600
SNDL Inc. · SNDL
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $44.8M | $547M | $673M | $672M | $677M |
| Revenue growth | −1.4% | 1,121.8% | 23.1% | −0.2% | 0.7% |
| Gross margin | −16.0% | 19.7% | 20.9% | 26.1% | 27.3% |
| Operating margin | −239.4% | −48.8% | −18.0% | −11.3% | −0.7% |
| Net income | −$181M | −$257M | −$128M | −$69.2M | −$11.3M |
| Net margin | −404.4% | −47.1% | −19.0% | −10.3% | −1.7% |
| Diluted EPS | — | −$1.12 | −$0.50 | −$0.26 | −$0.04 |
| Cash | |||||
| Cash from operations | −$124M | −$5.2M | −$12.3M | $40.1M | $50.7M |
| Capital expenditure | $3.0M | $8.2M | $5.8M | $6.3M | $9.2M |
| Free cash flow | −$127M | −$13.3M | −$18.1M | $33.8M | $41.6M |
| FCF margin | −284.3% | −2.4% | −2.7% | 5.0% | 6.1% |
| Share buybacks | $0.0M | $10.3M | $1.1M | $9.6M | $11.0M |
| Share count change | 749.3% | 23.6% | 12.8% | 1.9% | −2.3% |
| Debt and strength | |||||
| Cash and short-term investments | $439M | $207M | $147M | $152M | $184M |
| Shareholders' equity | $1.0B | $965M | $915M | $788M | $804M |
| Current ratio | 11.1x | 5.6x | 3.9x | 5.1x | 4.9x |
| Interest coverage | −3,360.3x | −1,954.2x | −2,014.9x | −14.5x | −0.9x |
| Returns and quality | |||||
| Return on equity | −28.8% | −25.6% | −13.6% | −8.1% | −1.4% |
| Return on tangible equity | −19.1% | −29.9% | −16.6% | −10.5% | −1.7% |
| Piotroski F-score | 4 | 3 | 4 | 6 | 5 |
| Altman Z'' | 14.8 | 3.8 | 3.1 | 3.6 | 3.5 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
SNDL Inc. · SNDL
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Source: SEC EDGAR XBRL filings (CIK 0001766600). Data updated October 24, 2026. Filed in CAD under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.